Tags: Drug.

56-Methylenedioxy-N-methyl-2-aminoindane (MDMAI) is a drug developed in the 1990s by a team led by David E. Nichols at Purdue University. It acts as a non-neurotoxic and highly selective serotonin releasing agent (SSRA) in animals and a putative entactogen in humans.

MDMAI.svg
ATC prefix
none
CAS number
132741-82-3
IUPAC name
N-methyl-67-dihydro-5H-cyclopenta[f][13]benzodioxol-6-amine
PubChem
125559

Loading...

This page contains content from the copyrighted Wikipedia article "56-Methylenedioxy-N-methyl-2-aminoindane"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.